Für eine einfachere Navigation sollten Sie dieses Kästchen angekreuzt lassen. Bei öffentlich zugänglichen Geräten empfehlen wir Ihnen, sich nach der Nutzung von Euroquity abzumelden
E-Mail

Für die Erstellung eines neuen Passworts erhalten Sie eine E-Mail

Ort

Wählen Sie Ihr Land

und Ihre Sprache

Guten Tag ,

Herzlich willkommen auf Ihrer persönlichen Profilseite! Machen Sie Angaben zu sich selbst, damit Sie für Organisationen, die für Sie von Interesse sind, besser sichtbar werden.

% fertiggestellt

%

Company

Rius Medical

Rius Medical_logo
17
EQ SCORE

Der EQ Score gibt die Aktivität und Attraktivität des Unternehmens auf der Plattform an: Vollständigkeit des Profils, Aktualität, Likes, Follows, Zugehörigkeit zu einem/einer oder mehreren Labels oder Communities, Anzahl der Mitglieder seines Netzwerks usw.

Rius Medical mission is to make its proprietary highly innovative platform available at year 2 to pharmaceutical and biotech partners - Proprietary cell lines for drug delivery. Engineer stem cells for next generation therapeutics as core business.

Waldachtal, Baden-Württemberg, Germany

Send a message

Englisch

Rius Medical

Englisch

Cell & Gene Therapy will shape the future of medicine, when novel technologies proceed beyond the primary goals of safety and efficacy. Uneconomical manufacturing is an industry challenge and represents a major roadblock to the sustainable commercialisation of cellular products. 

The solution, Rius Medical technology engineers stem cells into therapeutic products. Offering a Business-to-Business solution to U.S. based company Rubius Therapeutics and France-based Erytech...

See more

Cell & Gene Therapy will shape the future of medicine, when novel technologies proceed beyond the primary goals of safety and efficacy. Uneconomical manufacturing is an industry challenge and represents a major roadblock to the sustainable commercialisation of cellular products. 

The solution, Rius Medical technology engineers stem cells into therapeutic products. Offering a Business-to-Business solution to U.S. based company Rubius Therapeutics and France-based Erytech Pharma for upgraded red blood cells that do more than simply carry oxygen. For example Erytech Pharma’s therapeutic product is Phase III approved for Acute Lymphoblastic Leukemia and Phase II approved for Pancreatic Cancer.

Rius Medical is seeking a 30.000 euro financing such as a Convertible Loan of 30.000 euro, at a discounted rate of 0,50 euro per share, to help bridge the 2-3 months time for medifundo to bring 300.000 euro equity capital if not 600.000 euro.

Rius Medical implements innovation targeting Rare Diseases, Oncology and Autoimmune Diseases like type 1 diabetes, all within one platform technology! 

Beyond providing solutions for global healthcare’s biggest cost drivers, an EXIT opportunity at 3 years for early investors joining this Series A investment round of up to 1 million euro and pre-money valuation at 4 million euro will result in EUR 54 million financial benefit for FIVE products or EUR 10,5 million financial benefit for TWO products at 3 years to early investors.

  • 3

    Followers

Our latest news

Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Communities

ESIL - Early Stage Investing Launchpad
Early Stage Investing Launchpad has the overall objective of developing and boosting the activities for Business Angels through an international capacity building program
409 Members
InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1215 Members

Our history

Start in 31 August 2016

  • 31 August 2016

    registration with the commercial register of Stuttgart local court under folio HRB 757947

to be continued ...